Substrate Modulation of Enzyme Activity in the Herpesvirus Protease Family

Journal of Molecular Biology

Volumn 373, Issue 4, 2007, Pages 913-923

  Lazic, Ana ^a   Goetz, David H ^a   Nomura, Anson M ^a   Marnett, Alan B ^a   Craik, Charles S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

allostery; induced fit; protein protein interactions; viral protease; X ray structure

Indexed keywords

ANION; DIMER; ENZYME INHIBITOR; HEXAPEPTIDE; PROTEINASE; TETRAPEPTIDE; TYROSINE; VIRUS ENZYME;

ARTICLE; BINDING SITE; CATALYSIS; DIMERIZATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BINDING; ENZYME MECHANISM; ENZYME SPECIFICITY; ENZYME STABILITY; ENZYME STRUCTURE; ENZYME SUBSTRATE; ENZYME SUBSTRATE COMPLEX; HERPES VIRUS; KAPOSI SARCOMA; PRIORITY JOURNAL; PROTEIN FAMILY; STRUCTURE ACTIVITY RELATION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

EID: 34848849027     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.07.073     Document Type: Article

References (50)

1. Darke P.L., Cole J.L., Waxman L., Hall D.L., Sardana M.K., and Kuo L.C. Active human cytomegalovirus protease is a dimer. J. Biol. Chem. 271 (1996) 7445-7449
2. Schmidt U., and Darke P.L. Dimerization and activation of the herpes simplex virus type 1 protease. J. Biol. Chem. 272 (1997) 7732-7735
3. Batra R., Khayat R., and Tong L. Molecular mechanism for dimerization to regulate the catalytic activity of human cytomegalovirus protease. Nature Struct. Biol. 8 (2001) 810-817
4. Marnett A.B., Nomura A.M., Shimba N., Ortiz de Montellano P.R., and Craik C.S. Communication between the active sites and dimer interface of a herpesvirus protease revealed by a transition-state inhibitor. Proc. Natl Acad. Sci. USA 101 (2004) 6870-6875
5. Nomura A.M., Marnett A.B., Shimba N., Dotsch V., and Craik C.S. Induced structure of a helical switch as a mechanism to regulate enzymatic activity. Nature Struct. Mol. Biol. 8 (2005) 1019-1020
6. Nomura A.M., Marnett A.B., Shimba N., Dotsch V., and Craik C.S. One functional switch mediates reversible and irreversible inactivation of a herpesvirus protease. Biochemistry 45 (2006) 3572-3579
7. Weinheimer S.P., McCann III P.J., O'Boyle II D.R., Stevens J.T., Boyd B.A., Drier D.A., et al. Autoproteolysis of herpes simplex virus type 1 protease releases an active catalytic domain found in intermediate capsid particles. J. Virol. 67 (1993) 5813-5822
8. Donaghy G., and Jupp R. Characterization of the Epstein-Barr virus proteinase and comparison with the human cytomegalovirus proteinase. J. Virol. 69 (1995) 1265-1270
9. Gao M., Matusick-Kumar L., Hurlburt W., DiTusa S. F., Newcomb W.W., Brown J.C., et al. The protease of herpes simplex virus type 1 is essential for functional capsid formation and viral growth. J. Virol. 68 (1994) 3702-3712
10. Unal A., Pray T.R., Lagunoff M., Pennington M.W., Ganem D., and Craik C.S. The protease and the assembly protein of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). J. Virol. 71 (1997) 7030-7038
11. Brignole E.J., and Gibson W. Enzymatic activities of human cytomegalovirus maturational protease assemblin and its precursor (pPR, pUL80a) are comparable: [corrected] maximal activity of pPR requires self-interaction through its scaffolding domain. J. Virol. 81 (2007) 4091-4103
12. Pray T.R., Reiling K.K., Demirjian B.G., and Craik C. S. Conformational change coupling the dimerization and activation of KSHV protease. Biochemistry 41 (2002) 1474-1482
13. Robertson B.J., McCann III P.J., Matusick-Kumar L., Newcomb W.W., Brown J.C., Colonno R.J., and Gao M. Separate functional domains of the herpes simplex virus type 1 protease: evidence for cleavage inside capsids. J. Virol. 70 (1996) 4317-4328
14. DiIanni C.L., Drier D.A., Deckman I.C., McCann III P. J., Liu F., Roizman B., et al. Identification of the herpes simplex virus-1 protease cleavage sites by direct sequence analysis of autoproteolytic cleavage products. J. Biol. Chem. 268 (1993) 2048-2051
15. Baum E.Z., Bebernitz G.A., Hulmes J.D., Muzithras V.P., Jones T.R., and Gluzman Y. Expression and analysis of the human cytomegalovirus UL80-encoded protease: identification of autoproteolytic sites. J. Virol. 67 (1993) 497-506
16. Preston V.G., Rixon F.J., McDougall I.M., McGregor M., and al Kobaisi M.F. Processing of the herpes simplex virus assembly protein ICP35 near its carboxy terminal end requires the product of the whole of the UL26 reading frame. Virology 186 (1992) 87-98
17. Kennard J., Rixon F.J., McDougall I.M., Tatman J. D., and Preston V.G. The 25 amino acid residues at the carboxy terminus of the herpes simplex virus type 1 UL26.5 protein are required for the formation of the capsid shell around the scaffold. J. Gen. Virol. 76 (1995) 1611-1621
18. Reiling K.K., Pray T.R., Craik C.S., and Stroud R.M. Functional consequences of the Kaposi's sarcoma-associated herpesvirus protease structure: regulation of activity and dimerization by conserved structural elements. Biochemistry 39 (2000) 12796-12803
19. Tong L., Qian C., Massariol M.J., Deziel R., Yoakim C., and Lagace L. Conserved mode of peptidomimetic inhibition and substrate recognition of human cytomegalovirus protease. Nature Struct. Biol. 5 (1998) 819-826
20. Khayat R., Batra R., Qian C., Halmos T., Bailey M., and Tong L. Structural and biochemical studies of inhibitor binding to human cytomegalovirus protease. Biochemistry 42 (2003) 885-891
21. Ogilvie W., Bailey M., Poupart M.A., Abraham A., Bhavsar A., Bonneau P., et al. Peptidomimetic inhibitors of the human cytomegalovirus protease. J. Med. Chem. 40 (1997) 4113-4135
22. Bertrand J.A., Oleksyszyn J., Kam C.M., Boduszek B., Presnell S., Plaskon R.R., et al. Inhibition of trypsin and thrombin by amino(4-amidinophenyl)methanephosphonate diphenyl ester derivatives: X-ray structures and molecular models. Biochemistry 35 (1996) 3147-3155
23. Tong L., Qian C., Massariol M.J., Bonneau P.R., Cordingley M.G., and Lagace L. A new serine-protease fold revealed by the crystal structure of human cytomegalovirus protease. Nature 383 (1996) 272-275
24. Qiu X., Culp J.S., DiLella A.G., Hellmig B., Hoog S.S., Janson C.A., et al. Unique fold and active site in cytomegalovirus protease. Nature 383 (1996) 275-279
25. Hoog S.S., Smith W.W., Qiu X., Janson C.A., Hellmig B., McQueney M.S., et al. Active site cavity of herpesvirus proteases revealed by the crystal structure of herpes simplex virus protease/inhibitor complex. Biochemistry 36 (1997) 14023-14029
26. Buisson M., Hernandez J.F., Lascoux D., Schoehn G., Forest E., Arlaud G., et al. The crystal structure of the Epstein-Barr virus protease shows rearrangement of the processed C terminus. J. Mol. Biol. 324 (2002) 89-103
27. Khayat R., Batra R., Massariol M.J., Lagace L., and Tong L. Investigating the role of histidine 157 in the catalytic activity of human cytomegalovirus protease. Biochemistry 40 (2001) 6344-6351
28. La S.R., Aubry N., Bonneau P.R., Cameron D.R., Lagace L., Massariol M.J., et al. Human cytomegalovirus protease complexes its substrate recognition sequences in an extended peptide conformation. Biochemistry 37 (1998) 9793-9801
29. Bonneau P.R., Grand-Maitre C., Greenwood D.J., Lagace L., LaPlante S.R., Massariol M.J., et al. Evidence of a conformational change in the human cytomegalovirus protease upon binding of peptidyl-activated carbonyl inhibitors. Biochemistry 36 (1997) 12644-12652
30. Koshland Jr. D.E. Protein and biological control. Sci. Am. 229 (1973) 52-64
31. Liang P.H., Brun K.A., Feild J.A., O'Donnell K., Doyle M.L., Green S.M., et al. Site-directed mutagenesis probing the catalytic role of arginines 165 and 166 of human cytomegalovirus protease. Biochemistry 37 (1998) 5923-5929
32. Hedstrom L. Serine protease mechanism and specificity. Chem. Rev. 102 (2002) 4501-4524
33. Perona J.J., and Craik C.S. Evolutionary divergence of substrate specificity within the chymotrypsin-like serine protease fold. J. Biol. Chem. 272 (1997) 29987-29990
34. Perona J.J., and Craik C.S. Structural basis of substrate specificity in the serine proteases. Protein Sci. 4 (1995) 337-360
35. Buisson M., Valette E., Hernandez J.F., Baudin F., Ebel C., Morand P., et al. Functional determinants of the Epstein-Barr virus protease. J. Mol. Biol. 311 (2001) 217-228
36. Lagunoff M., Bechtel J., Venetsanakos E., Roy A.M., Abbey N., Herndier B., et al. De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells. J. Virol. 76 (2002) 2440-2448
37. Jing H., Babu Y.S., Moore D., Kilpatrick J.M., Liu X. Y., Volanakis J.E., and Narayana S.V. Structures of native and complexed complement factor D: implications of the atypical His57 conformation and self-inhibitory loop in the regulation of specific serine protease activity. J. Mol. Biol. 282 (1998) 1061-1081
38. Xu Y., Narayana S.V., and Volanakis J.E. Structural biology of the alternative pathway convertase. Immunol. Rev. 180 (2001) 123-135
39. Pray T.R., Nomura A.M., Pennington M.W., and Craik C.S. Auto-inactivation by cleavage within the dimer interface of Kaposi's sarcoma-associated herpesvirus protease. J. Mol. Biol. 289 (1999) 197-203
40. Leslie A.G.W. Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4 + ESF-EAMCB Newsletter on Protein Crystallography vol. 26 (1992)
41. Evans P.R. "Data Reduction", Proceedings of CCP4 Study Weekend, 1993, on Data Collection and Processing (1993) 114-122
42. Vagin A., and Teplyakov A. MOLREP: an automated program for molecular replacement. J. Appl. Crystallog. 30 (1997) 1022-1025
43. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallog. sect. D 60 (2004) 2126-2132
44. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallog. sect. D 53 (1997) 240-255
45. Winn M.D., Isupov M.N., and Murshudov G.N. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallog. sect. D 57 (2001) 122-133
46. Krissinel E., and Henrick K. Detection of protein assemblies in crystals. In: Berthold M.R. (Ed). Computational Life Sciences vol. 3695 (2005), Springer, Berlin, Heidelberg 163-174
47. Eisenberg D., and McLachlan A.D. Solvation energy in protein folding and binding. Nature 319 (1986) 199-203
48. Fersht A.R. Chemical basis of biological specificity. Pure Appl. Chem. 54 (1982) 1819-1824
49. Harris J.L., Backes B.J., Leonetti F., Mahrus S., Ellman J.A., and Craik C.S. Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries. Proc. Natl. Acad. Sci. USA 97 (2000) 7754-7759
50. Wallace A.C., Laskowski R.A., and Thornton J.M. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8 (1995) 127-134